Today’s Rating: Steris (NYSE:STE) Is Reaching An Inflection Point; Goldman Starts At “Neutral” with $71 target

November 30, 2016 - By Peter Kolinski

Today's Rating: Steris (NYSE:STE) Is Reaching An Inflection Point; Goldman Starts At

Why Goldman Gives Steris (NYSE:STE) $71 Price Target

Equity research analysts at Goldman started coverage on shares of Steris (NYSE:STE) in a analysts report made public on Wednesday, 30 November. The financial company set a “Neutral” rating on the stock. Goldman’s price target of $71 suggests potential of 6.46% from the stock’s last price.

STERIS plc Ordinary Shares (NYSE:STE) Ratings Coverage

Out of 2 analysts covering Steris (NYSE:STE), 2 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. $84 is the highest target while $82 is the lowest. The $83 average target is 24.46% above today’s ($66.69) stock price. Steris has been the topic of 3 analyst reports since November 2, 2015 according to StockzIntelligence Inc. The stock of STERIS plc Ordinary Shares (NYSE:STE) earned “Buy” rating by Northcoast on Friday, June 3.

About 27,622 shares traded hands. STERIS plc Ordinary Shares (NYSE:STE) has declined 7.62% since April 27, 2016 and is downtrending. It has underperformed by 12.85% the S&P500.

Analysts await STERIS plc Ordinary Shares (NYSE:STE) to report earnings on February, 14. They expect $1.04 EPS, up 6.12% or $0.06 from last year’s $0.98 per share. STE’s profit will be $88.89M for 16.03 P/E if the $1.04 EPS becomes a reality. After $0.89 actual EPS reported by STERIS plc Ordinary Shares for the previous quarter, Wall Street now forecasts 16.85% EPS growth.

Insitutional Activity: The institutional sentiment decreased to 0.45 in 2016 Q2. Its down 1.15, from 1.6 in 2016Q1. The ratio worsened, as 0 funds sold all STERIS plc Ordinary Shares shares owned while 5 reduced positions. 6 funds bought stakes while 2 increased positions. They now own 350,212 shares or 21.74% more from 287,671 shares in 2016Q1.

Lmr Prtn Llp holds 0.92% or 86,749 shares in its portfolio. Gsa Cap Partners Llp last reported 0.02% of its portfolio in the stock. Westpac accumulated 2,733 shares or 0% of the stock. Vantage Investment Advsr Lc holds 0% of its portfolio in STERIS plc Ordinary Shares (NYSE:STE) for 20 shares. Bragg Inc holds 0.21% or 17,137 shares in its portfolio. Citigroup holds 0% of its portfolio in STERIS plc Ordinary Shares (NYSE:STE) for 6,913 shares. West Coast Ltd holds 2.07% of its portfolio in STERIS plc Ordinary Shares (NYSE:STE) for 83,293 shares. Penobscot Inv last reported 0.07% of its portfolio in the stock. Yorktown Mgmt & Research holds 0.07% of its portfolio in STERIS plc Ordinary Shares (NYSE:STE) for 4,500 shares. Moreover, Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Mgmt has 0.04% invested in STERIS plc Ordinary Shares (NYSE:STE) for 51,090 shares. Ghp Investment Advisors Incorporated owns 27,728 shares or 0.41% of their US portfolio. Axiom International Limited Liability De has invested 0.05% of its portfolio in STERIS plc Ordinary Shares (NYSE:STE). Moreover, Huntington Comml Bank has 0% invested in STERIS plc Ordinary Shares (NYSE:STE) for 1,598 shares. 12Th Street Asset Mngmt Communications Limited Liability holds 0.7% of its portfolio in STERIS plc Ordinary Shares (NYSE:STE) for 25,760 shares. Mackenzie Corp last reported 0% of its portfolio in the stock.

According to Zacks Investment Research, “Steris Plc provide infection prevention, contamination control, microbial reduction, and procedural support products and services for healthcare, pharmaceutical, scientific, research, industrial and governmental customers. The Company’s operating segments consists of Healthcare, Life Sciences and STERIS Isomedix Services. Healthcare segment manufactures and sells capital equipment, accessory, consumables, information support and service solutions to healthcare providers, including acute care hospitals and surgery and gastrointestinal centers. Life Sciences segment manufactures and sells a range of capital equipment, formulated cleaning chemistries and service solutions to pharmaceutical companies and private and public research facilities. Isomedix segment sells an array of contract processing services as well as laboratory testing services. Steris Plc, formerly known as STERIS Corporation, is headquartered in Leicester, United Kingdom.”

More important recent STERIS plc Ordinary Shares (NYSE:STE) news were published by: Equitiesfocus.com which released: “STERIS Corporation (NYSE:STE) PEG Ratio At 1.68” on November 25, 2016, also Equitiesfocus.com published article titled: “STERIS Corporation (NYSE:STE) 200-Day MA At $70.05”, Equitiesfocus.com published: “STERIS Corporation (NYSE:STE) Short-Term Price Target At $85.83” on November 16, 2016. More interesting news about STERIS plc Ordinary Shares (NYSE:STE) was released by: Investorplace.com and their article: “5 Dividend Stocks Increasing Payouts – MO INTU STE MLM MGEE” with publication date: August 29, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>